Antibiotic Selection for Gram-Positive Cocci Infections
First-Line Options
- For beta-lactam-susceptible gram-positive cocci, an anti-staphylococcal penicillin or first-generation cephalosporin should be used as they are more rapidly bactericidal than vancomycin 2, 3
- For streptococcal infections, penicillin G remains the drug of choice for susceptible strains, with cefazolin as an alternative 1
- For community-acquired MRSA skin and soft tissue infections, oral options include trimethoprim-sulfamethoxazole, tetracyclines, linezolid, and tedizolid 4
When to Use Vancomycin
- Vancomycin should be reserved for treatment of serious infections caused by beta-lactam-resistant gram-positive organisms 2, 3
- Vancomycin should be used for treatment of gram-positive infections in patients with serious allergies to beta-lactam antimicrobials 2, 3
- Empiric therapy with vancomycin is recommended when MRSA is suspected based on local prevalence or patient risk factors 5, 1
Alternative Agents for Resistant Gram-Positive Cocci
- Daptomycin is particularly effective for bacteremia and endocarditis 4
- Linezolid has excellent bioavailability for oral step-down therapy 4
- Ceftaroline is the only beta-lactam with activity against MRSA 4
- Dalbavancin is a long-acting glycopeptide allowing for less frequent dosing 4
Special Considerations
- For vancomycin-resistant enterococci, linezolid or daptomycin are preferred 1
- Duration of therapy typically ranges from 7-14 days but should be based on clinical response 4
Common Pitfalls to Avoid
- Using vancomycin empirically when not indicated contributes to development of resistance 2, 6, 3
- Continuing vancomycin when cultures are negative for beta-lactam-resistant organisms is not recommended 3
- Failing to monitor vancomycin levels in patients with impaired renal function is a common pitfall 1
- Delaying appropriate therapy for severe infections increases mortality 1
Algorithmic Approach to Gram-Positive Cocci Infections
- Identify the organism and obtain susceptibility testing 1
- For susceptible strains, use beta-lactams as first choice 1
- For MRSA or beta-lactam allergies, use vancomycin 3
- Consider local resistance patterns when selecting empiric therapy 1
- De-escalate to narrower spectrum agents once susceptibilities are known 1